(Published September 2004)

Publication Information

Clinical Advisors

ARHP would like to thank the following clinical experts for their assistance in preparing this monograph.

Linda Andrist, PhD, RNC, WHNP
Associate Professor and Coordinator
Women’s Health NP Program
MGH Institute of Health Professions
Boston, MA

Jeffrey T. Jensen, MD, MPH
Leon Speroff Professor of Obstetrics and Gynecology
Oregon Health and Science University
Portland, OR

Andrew M. Kaunitz, MD, co-chair
Professor and Assistant Chairman
University of Florida, Health Science Center
Jacksonville, FL

Susan Wysocki, RN-C, NP, co-chair
President and CEO
National Association of Nurse Practitioners in Women’s Health
Washington, DC

Financial Disclosure Information

Andrist: Advisory board for Berlex Laboratories.

Jensen: Receives grant/research support from Berlex Laboratories; National Institute of Child Health and Human Development, National Institutes of Health; Organon Pharmaceuticals USA, Inc.; Pfizer, Inc.; Warner Chilcott, Inc.; and Wyeth Pharmaceuticals. Speaker for Organon Pharmaceuticals USA, Inc.; Pfizer, Inc.; and Wyeth Pharmaceuticals. Advisory board for Wyeth Pharmaceuticals.

Kaunitz: Receives grant/research support from Barr Laboratories, Inc.; Berlex Laboratories; Galen Pharmaceutical; Johnson & Johnson; the National Institutes of Health; and Pfizer, Inc. Speaker and/or consultant for Aventis Pharmaceuticals, Inc.; Barr Laboratories, Inc.; Berlex Laboratories; Johnson & Johnson; Pfizer, Inc.; and Procter & Gamble. Continuing medical education presentations and publications for Aventis Pharmaceuticals, Inc.; Berlex Laboratories; Ortho-McNeil Pharmaceutical, Inc.; Pfizer, Inc.; and Procter & Gamble. Stockholder in Johnson & Johnson; Noven Pharmaceuticals, Inc.; and Pfizer, Inc.

Wysocki: Speaker for 3M Corporation; Barr Laboratories, Inc.; Berlex Laboratories; Eli Lilly and Co.; Novo Nordisk.; Organon Pharmaceuticals USA, Inc.; Ortho-McNeil Pharmaceutical, Inc.; and Pfizer, Inc. Advisory board for 3M Corporation; Barr Laboratories, Inc.; Berlex Laboratories; Eli Lilly and Co.; Merck & Co., Inc.; Novavax, Inc.; Novo Nordisk; Ortho-McNeil Pharmaceutical, Inc.; Pfizer, Inc.; and Solvay Pharmaceuticals, Inc.

ARHP Board of Directors

Lee Lee Doyle, PhD, Chair
Felicia H. Stewart, MD, Immediate Past Chair
Barbara Clark, PA-C, Secretary
Lee P. Shulman, MD, Treasurer
Mitchell Creinin, MD, Chair, Education Committee
Wayne C. Shields, President and CEO

Louise Bateman, NP
Henry W. Foster, Jr., MD
Pablo Rodriguez, MD
Sharon Schnare, RN, FNP, CNM, MSN
Carolyn Westhoff, MD
Sandy Worthington, RNC, NP, CNM

Vanessa Cullins, MD, MPH, MBA
PPFA Vice President for Medical Affairs
Scott J. Spear, MD
PPFA National Medical Committee Representative

Anne Moore, RNC, MSN, FAANP, Chair-Elect
Linda Dominguez, RNC, BSN, WHNP, Chair
Carolyn M. Sutton, MS, RNC, WHCNP, Secretary
Beth Kelsey, MS, RNC, NP, Treasurer
Sarah B. Freeman, PhD, ARNP, FAANP, Immediate Past Chair

Ivy M. Alexander, PhD, MS, C-ANP
North Atlantic Region

Penelope M. Bosarge, MSN, CRNP, WHNP
Southeast Region

Susan Kendig, RNC, MSN, WHCNP
South Central Region

Suzy Reiter, RNC, NP, MM, MSN
Great Lakes Region

Sharon Myoji Schnare, RN, FNP, CNM, MSN
Western Region

Diane A. Smith, RN, MSN, CRNP
Versie Johnson-Mallard, MSN, ARNP
Mary Ann Nihart, MA, APRN, CS, BC

Elizabeth S. Callihan, Designer
Rachel S. Fey, ARHP Education Associate
Cynthia M. Lopez, ARHP Education Manager
Nancy Monson, Consulting Writer
Deborah Shuman, MD, Consulting Editor
Wayne C. Shields, ARHP President and CEO
Amy M. Swann, ARHP Director of Education
Susan Wysocki, RNC, NP, NPWH President and CEO